Small Bones Fuel Growth in US Fracture Fixation Market
This article was originally published in Start Up
The US market for fracture fixation products is growing at a compound annual rate of about 7.6% and is expected to reach over $4.7 billion in sales by 2012, according to Windhover Information/Medtech Insight's recently published report, US Markets for Orthopedic Implant, Reconstruction, and Trauma Products. Fixation devices for use in the small bones are expected to post the strongest growth by far.
You may also be interested in...
Long a pioneer in prosthetics, one of orthopedics' forgotten spaces, Stanmore Implants Worldwide, has a new investor group who hope to transform this once academic supplier into a thriving orthopedics player by focusing on specialty niches that the Ortho giants have largely ignored.
Founded in 1989 Integra avoided the sad fates of its peers in tissue engineering (which went bankrupt) by adopting an acquisition strategy that took it into surgical product markets. Integra has enjoyed a compound annual revenue growth rate of 36% since it first embarked on its acquisition strategy in 1999. Its secret of success has been to consolidate fragmented niche markets into which it can create additional value by selling its internally-developed tissue-engineered products. Now, with six operating divisions covering four surgical specialties with a multiplicity of call points, it looks and acts like a large, diversified medical device company. But it's not-with $650 million in revenues, it's a mid-sized company. Can it now, as a mid-sized company with a complicated business, sustain its high level of growth through a combination of acquisitions and organic growth?
OrthoHelix Surgical Designs aims to bring cohesion to the fragmented small bone and joint marketplace. Unlike other small companies in the space, which typically offer products that address a single application, OrthoHelix is building an integrated suite of products designed to address most of the small bone surgeon's needs.